The FDA approved Eli Lilly's Onsewik, a weekly insulin injection for type 2 diabetes patients that is administered once a week instead of daily. In four trials with more than 3,400 participants, it stabilized blood sugar levels to a similar extent as daily injections. Novo Nordisk's competing weekly insulin was approved in the United States already half a year ago, and in a few weeks it is expected to arrive in Israel.
Automatic translation by Google
Curated from Ynet Health. Classified as Health by AI, which sometimes makes mistakes.
Simple, useful, and kind of fun. The post Doctor shares 60-second dementia test that can help adults spot early mental decline appeared first on Upworthy.
Many people dealing with excess weight know the feeling: every attempt ends up in the same place. Weight loss, weight gain, and the sense that eventually "maybe nothing will work for me." Professor Itamar Raz, an expert in obesity and diabetes, knows this feeling well from the clinic, and suggests changing the mindset.
What should you do when a doctor recommends a critical and expensive medication that is not included in the public health basket, but the insurance company rejects the request, claiming the insurance policy lacks coverage? Before you exhaust savings or break down over a denial letter from the insurer, it is important to understand the financing mechanisms operating behind the scenes. A guide to exercising patient rights in Israel.
